Medicinal Products

Azacitidin Pharmascience 25 mg/ml prašak za suspenziju za injekciju

Name Azacitidin Pharmascience 25 mg/ml prašak za suspenziju za injekciju
Marketing Authorisation Number HR-H-961547190
Active Substance azacitidin
Composition Jedna bočica s praškom sadrži 100 mg ili 150 mg azacitidina. Nakon rekonstitucije 1 ml suspenzije sadrži 25 mg azacitidina.
Pharmaceutical Form prašak za suspenziju za injekciju
Manufacturer AqVida GmbH, Hamburg, Njemačka
Marketing Authorisation Holder Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar
Marketing Authorisation Date 08.08.2025
MA Period of Validity unlimited
Classification Number UP/I-530-09/25-02/58
Registration Number 381-12-01/286-25-07
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to restricted medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code L01BC07
Marketing status Never marketed
SmPC download
PL download
Public Assessment Report download
Summary of risk management plan download

Packaging

Back